Skip to main content
. 2026 Apr 1;17:1782968. doi: 10.3389/fphar.2026.1782968

TABLE 2.

Descriptive statistics for pharmacological risk components and PsychoPharm Aggregated Risk Score (PARS) at the visit level, displayed with standard deviation (SD), and interquartile range (IQR).

Risk components/scores Mean ± SD Median (IQR) Min–Max
DDIscore 15.62 ± 17.99 8.50 (3.00–21.00) 0.00–136.00
ACB score visit 2.51 ± 2.01 2.00 (1.00–4.00) 0.00–14.00
AZCERTmax 1.56 ± 0.80 2.00 (1.00–2.00) 0.00–3.00
PARS 0.00 ± 0.64 − 0.02 ( − 0.32–0.39) − 1.46–3.03
PARS rescaled 3.25 ± 1.43 3.19 (2.53–4.12) 0.00–10.00
Binary indicators n (or n = 1) % (if binary) ​
SEROany 2,227 83.5
Has polypharmacy 1,297 48.6
High-risk PARS 671 25.2